Detection of tumor marker CA125 in ovarian carcinoma using quantum dots

Acta Biochimica et Biophysica Sinica

Volumn 36, Issue 10, 2004, Pages 681-686

  Wang, Hui Zhi ^a   Wang, Hai Yan ^a   Liang, Ru Qiang ^a   Ruan, Kang Cheng ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Detection of tumor marker CA125; Ovarian carcinoma; Quantum dots

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; TUMOR MARKER;

ARTICLE; FLAME PHOTOMETRY; FLUORESCENCE; HUMAN; ILLUMINATION; IMMUNOHISTOCHEMISTRY; LASER; OVARY CARCINOMA; QUANTUM CHEMISTRY; SEMICONDUCTOR; XENOGRAFT;

EID: 10044296301     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: 10.1093/abbs/36.10.681     Document Type: Article

References (22)

1. Hall M, Kazakova I, Yao YM. High sensitivity immunoassays using particulate fluorescent labels. Anal Biochem, 1999, 272(2): 165-170
2. Hermanson GT. Bioconjugate Techniques. 2nd ed. London: Academic Press, 1996, 297-416
3. Alivisatos AP. Semiconductor clusters, nanocrystals, and quantum dots. Science, 1996, 271: 933-937
4. Nirmal M, Brus L. Luminescence photophysics in semiconductor nanocrystals. Ace Chem Res, 1999, 32: 407-414
5. Henglein A. Small-particle research: Physiochemical properties of extremely small colloidal metal and semiconductor particles. Chem Rev, 1989, 89: 1861-1873
6. Klarreich E. Biologists join the dots. Nature, 2001, 413: 450-452
7. Mitchell P. Turning the spotlight on cellular imaging. Nat Biotechnol, 2001, 19: 1013-1017
8. Bruchez M Jr, Moronne M, Gin P, Weiss S, Alivisatos AP. Semiconductor nanocrystals as fluorescent biological labels. Science, 1998, 281: 2013-2016
9. Achermann M, Petruska MA, Kos S, Smith DL, Koleske DD, Klimov VI. Energy-transfer pumping of semiconductor nanocrystals using an epitaxial quantum well. Nature, 2004, 429: 642-646
10. Pitsillides CM, Joe EK, Wei X, Anderson RR, Lin CP. Selective cells targeting with light-absorbing microparticles and nanoparticles. Biophys J, 2003, 84: 4023-4032
11. Chan WC, Nie S. Quantum dot bioconjugates for untrasensitive nonisotopic detection. Science, 1998, 281: 2016-2018
12. Larson DR, Zipfel WR, Williams RM, Clark SW, Bruchez MP, Wise FW, Webb WW. Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science, 2003, 300: 1434-1436
13. Wu X, Liu H, Liu J, Haley KN, Treadway JA, Larson PJ, Ge N et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol, 2003, 21: 41-46
14. Kaul Z, Yaguchi T, Kaul SC, Hirano T, Wadhwa R, Taira K. Mortalin imaging in normal and cancer cells with quantum dot immuno-conjugates. Cell Res, 2003, 13(6): 503-507
15. Jaiswal JK, Mattoussi H, Mauro JM, Simon SM. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotechnol, 2003, 21: 47-51
16. Watson A, Wu X, Bruchez M. Lighting up cells with quantum dots. Biotechniques, 2003, 34: 296-300
17. Akerman ME, Chan WCW, Laakkonen P, Bhatia SN, Ruoslahti E. Nanocrystal targeting in vivo. Proc Natl Acad Sci USA, 2002, 99: 12617-12621
18. Schuttes BC, Whiteside TL. Monitoring of immune responses to CA125 with an IFN-γ ELISPOT assay. J Immunol Methods, 2003, 279: 1-15
19. Niloff JM, Knapp RC, Schaetzl E, Reynolds C, Bast RC Jr. CA125 antigen levels in obstetric and gynecologic patients. Obstet Gynecol, 1984, 64: 703-707
20. Niloff JM, Klug TL, Schaetzl E, Zurawski VR Jr, Knapp RC, Bast RC Jr. Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix. Am J Obstet Gynecol, 1984, 148: 1057-1058
21. Paoletti AM, Serra GG, Mais V, Ajossa S, Guerriero S, Orru M, Melis GB. Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies. J Assist Reprod Genet, 1995, 12: 263-268
22. Liu YF. Immunohistochemistry. Peking: People Health Press, 1990, 150-168